Product
AdCLD-CoV19
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase 1/2a Study (Dose Escalation, Single Center, Open, Phase 1 and Multicenter, Open, Phase 2a) to Assess the Safety and Immunogenicity of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy VolunteersStatus: Completed, Estimated PCD: 2021-07-09